Fiera Capital Corp Sells 15,111 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Fiera Capital Corp reduced its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 4.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 349,865 shares of the medical instruments supplier’s stock after selling 15,111 shares during the period. Mettler-Toledo International accounts for approximately 1.3% of Fiera Capital Corp’s holdings, making the stock its 21st biggest position. Fiera Capital Corp owned about 1.66% of Mettler-Toledo International worth $428,123,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. State Street Corp raised its position in Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after purchasing an additional 9,009 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Mettler-Toledo International by 0.8% during the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after purchasing an additional 4,166 shares in the last quarter. Barclays PLC raised its holdings in Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after buying an additional 19,609 shares during the period. JPMorgan Chase & Co. increased its holdings in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after purchasing an additional 28,478 shares in the last quarter. Finally, Loomis Sayles & Co. L P lifted its position in shares of Mettler-Toledo International by 1.8% in the third quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after purchasing an additional 3,644 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Wolfe Research started coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Stifel Nicolaus decreased their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Robert W. Baird upped their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday. Finally, Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $1,368.00.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,313.20 on Thursday. The company has a 50 day simple moving average of $1,281.95 and a two-hundred day simple moving average of $1,341.62. The firm has a market cap of $27.71 billion, a PE ratio of 32.40, a PEG ratio of 4.80 and a beta of 1.13. Mettler-Toledo International Inc. has a 1 year low of $1,133.46 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 564.51%. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 41.94 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at $7,524.54. This represents a 95.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.94% of the stock is currently owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.